Tolerability, pharmacokinetics and pharmacodynamics of CMAB001, an anti-CD11a antibody, in Chinese healthy volunteers and psoriatic patients

导出学术成果认领

作者单位 International Cancer Research Institute,Second Military Medical University,Shanghai 200433,China;National EngineeringResearch Center of Antibody Medicine,Shanghai 201203,China;pLA General Hospital Cancer Center,PLA Postgraduate School of Medicine,Beijing 100853,China ^[1] Xi-nan Hospital,Third Military Medical University,Chongqing 400038,China ^[2]

关键词 chronic plaque psoriasis CD11a humanized antibody CMAB001 pharmacokinetics pharmacodynamics tolerability openlabel study

栏目名称 Pharmacokinetics

DOI 10.1038/aps.2012.65

发布时间 2012-10-29

基金项目

the National Natural Science Foundation of China,Shanghai Commission of Science & Technology,Ministry of Science and Technology of China National Key projects for New Drug Development and Manufacture,Shanghai Pudong Commission of Science & Technology and Shanghai Leading Academic Discipline Project (B905).Special thanks to the study subjects and referring physicians for their participation in this study

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览29
被引0
下载0

中国药理学报（英文版）

2012年8期

1085-1094页

SCIMEDLINEISTICCSCDCABP

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Tolerability, pharmacokinetics and pharmacodynamics of CMAB001, an anti-CD11a antibody, in Chinese healthy volunteers and psoriatic patients

中国药理学报（英文版）

相似文献

中国药理学报（英文版）

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Tolerability, pharmacokinetics and pharmacodynamics of CMAB001, an anti-CD11a antibody, in Chinese healthy volunteers and psoriatic patients

中国药理学报（英文版）

相似文献

中国药理学报（英文版）

相关期刊

检索历史清除